Skip to main content

Table 1 Incidence of autoantibodies to p53 compared with disease status at last clinic attendance

From: P53 autoantibodies in 1006 patients followed up for breast cancer

Disease status

% Anti-p53 positive

Primary remission

14.7% (82/557)

Secondary remission

17.4% (27/155)

Secondary recurrent

19.4% (20/103)

Continuous active

16.5% (24/145)

Total

15.9% (153/96)*

  1. Pearson χ2: P = 0.606. *Information on disease status at last sample time was available for 960 out of 1006 patients